These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2650086)

  • 1. Recombinant interleukin-2 (IL-2) can reverse the blood transfusion effect.
    Dallman MJ; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1165-7. PubMed ID: 2650086
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine A.
    Farges O; Buffello D; Shi YM; Moufetier A; Bismuth H
    Transplant Proc; 1995 Aug; 27(4):2525-7. PubMed ID: 7652915
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced kidney graft survival in rats by single or multiple blood transfusion(s) and various blood products.
    Martin DC; Hewitt CW; Osborne JG; Dowdy SF; Fristoe TL; Russell LA; Cote J
    Transplant Proc; 1982 Jun; 14(2):407-9. PubMed ID: 7051487
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
    Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxic cells alone are not sufficient to mediate renal graft rejection.
    Wood KJ; Dallman MJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):338-9. PubMed ID: 2650143
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of recombinant interleukin-2 (rIL-2) and large granular lymphocytes (LGLs) in acute rat graft-versus-host disease (GVHD).
    Clancy J; Goral J; Kovacs EJ; Ellis T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):88-9. PubMed ID: 2784908
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood transfusion induces specific cytotoxic cells.
    Wood KJ; Dallman MJ; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1458-60. PubMed ID: 3274354
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine.
    Gyopar AF; Loertscher R; Guttman RD; Tchervenkov JI
    Transplantation; 1993 May; 55(5):1199-202. PubMed ID: 8497904
    [No Abstract]   [Full Text] [Related]  

  • 9. Abolition of anti-CD4-induced allotransplantation tolerance by exogenous IL-2.
    Lehmann M; Risch K; Nizze H; Brandenburg G; Ritter T; Brock J; Volk HD
    Transplant Proc; 1999; 31(1-2):1220-1. PubMed ID: 10083545
    [No Abstract]   [Full Text] [Related]  

  • 10. The mechanism of platelet-induced rat renal allograft prolongation.
    Hibberd AD; Wood RA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1411-3. PubMed ID: 3274342
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
    Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
    Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of interleukin-2 receptor (IL-2R) monoclonal antibody (MAb) therapy: target cell depletion or inhibition of function?
    Tellides G; Dallman MJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):997-8. PubMed ID: 2650306
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of mouse xenogeneic T-cell responses and the effect of FK 506 on these responses and on xeno-skin graft rejection.
    Fukuzawa M; Okada A
    Transplant Proc; 1994 Apr; 26(2):972-4. PubMed ID: 7513483
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506.
    Fabrega AJ; Blanchard JM; Rivas PA; Pollak R
    Transplantation; 1993 Dec; 56(6):1579-80. PubMed ID: 7506458
    [No Abstract]   [Full Text] [Related]  

  • 15. Recipient blood pre-transplant transfusion prolongs hepatic allograft survival in rats.
    Wang FS; Yamaguchi Y; Furuhashi T; Uchino S; Kihara S; Yamada S; Mori K; Ogawa M
    J Surg Res; 2006 Sep; 135(1):52-60. PubMed ID: 16716354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of long-term rat renal allograft survival: a specific synergistic effect of limited pretransplant cyclosporine combined with multiple nonspecific blood transfusions.
    Martin DC; Hewitt CW; Black KS; Reyes M; Go C
    Transplant Proc; 1987 Feb; 19(1 Pt 1):462-3. PubMed ID: 3274807
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival.
    Kuroki H; Bean MA; Ikuta Y; Akiyama M; Burgess EM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):658-61. PubMed ID: 7679833
    [No Abstract]   [Full Text] [Related]  

  • 18. Lung transplantation in the rat: cellular mechanisms of allograft rejection.
    Pepper JR; Parfett GJ; Reader JA; Kirby JA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):470-2. PubMed ID: 2650180
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term residual cyclosporine levels following short-term administration in various allograft models demonstrating extensive survival prolongation.
    Hewitt CW; Black KS; Gonzalez GA; Dowdy SF; Reyes M; Martin DC; Achauer BM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1244-5. PubMed ID: 3274310
    [No Abstract]   [Full Text] [Related]  

  • 20. Localization of MHC antigens in long surviving rat renal allografts: probable implication of passenger leukocytes in graft adaptation.
    Hart DN; Fabre JW
    Transplant Proc; 1981 Mar; 13(1 Pt 1):95-9. PubMed ID: 7022913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.